千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2024.01.15
INSIDE INFORMATION ANNOUNCEMENT
2024.01.15
千亿国际:关于子公司重要事项的公告
2024.01.10
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 10,...
2024.01.10
千亿国际:2024年第一次临时股东大会决议公告
2023.12.29
DISSEMINATION OF CORPORATE COMMUNICATIONS
2023.12.19
千亿国际:关于联营公司君圣泰医药拟在香港联交所主板上市的公告
2023.12.18
VOLUNTARY ANNOUNCEMENT PROPOSED OFFERING AND LISTING OF SHARES OF HIGHTIDE THERA...
2023.12.18
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
2023.12.18
PROXY FORM
2023.12.18
NOTIFICATION LETTER
第一页
上一页
11
12
13
14
15
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.